Dong-Hua Yang Selected Research

Dong-Hua Yang Research Topics

Disease

75	Neoplasms (Cancer) 03/2024 - 05/2002
7	Carcinoma (Carcinomatosis) 01/2020 - 10/2002
6	Neoplasm Metastasis (Metastasis) 04/2023 - 10/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2014
6	Hepatocellular Carcinoma (Hepatoma) 05/2017 - 04/2000
5	Lung Neoplasms (Lung Cancer) 04/2023 - 01/2017
4	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2012
4	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2013
3	Colonic Neoplasms (Colon Cancer) 07/2021 - 08/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 05/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2022 - 03/2017
2	Triple Negative Breast Neoplasms 12/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
2	Adenocarcinoma 07/2017 - 01/2016
2	Carcinogenesis 01/2013 - 06/2004
2	Cysts 12/2003 - 10/2002
1	Residual Neoplasm 03/2024
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 12/2022
1	Thrombocytopenia (Thrombopenia) 12/2022
1	Polycythemia (Erythrocytosis) 12/2022
1	Reperfusion Injury 06/2022
1	Myocardial Infarction 06/2022
1	Pathologic Complete Response 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Liver Neoplasms (Liver Cancer) 04/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2002
10	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2020 - 01/2016
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2021 - 04/2011
6	Adenosine Triphosphate (ATP)IBA 07/2020 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 05/2014
4	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 12/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2022 - 01/2017
4	Topotecan (Hycamtin)FDA LinkGeneric 01/2021 - 06/2014
4	Antineoplastic Agents (Antineoplastics)IBA 07/2020 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
3	oridoninIBA 01/2020 - 01/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2013
2	AntigensIBA 03/2024 - 01/2023
2	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2023
2	Phosphotransferases (Kinase)IBA 12/2022 - 01/2019
2	EnzymesIBA 01/2022 - 11/2018
2	venetoclaxIBA 01/2022 - 02/2020
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021 - 01/2020
2	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2021 - 11/2020
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 07/2017
2	Messenger RNA (mRNA)IBA 05/2017 - 06/2004
2	CholesterolIBA 09/2015 - 01/2013
2	SterolsIBA 09/2015 - 01/2013
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2012 - 04/2011
2	Phosphodiesterase 5 InhibitorsIBA 08/2012 - 04/2011
2	Single-Chain AntibodiesIBA 05/2010 - 01/2001
2	Laminin (Merosin)IBA 10/2002 - 05/2002
2	CollagenIBA 10/2002 - 05/2002
1	Cyclin D1IBA 01/2023
1	Circular RNAIBA 01/2023
1	Mitochondrial RNAIBA 01/2023
1	LipidsIBA 01/2023
1	AllergensIBA 01/2023
1	Macrophage Colony-Stimulating FactorIBA 12/2022
1	Docetaxel (Taxotere)FDA Link 12/2022
1	Taxoids (Taxanes)IBA 12/2022
1	Interleukin-1 Receptor-Associated KinasesIBA 12/2022
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 12/2022
1	Carboplatin (JM8)FDA LinkGeneric 12/2022
1	Janus Kinase 2IBA 12/2022
1	geniposideIBA 06/2022
1	InflammasomesIBA 06/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	evodiamineIBA 12/2021
1	CurcuminIBA 07/2021
1	Phosphates (Orthophosphate)IBA 04/2021
1	TubulinIBA 04/2021
1	Proteolysis Targeting ChimeraIBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2021
1	SurvivinIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Tramadol (K315)FDA LinkGeneric 01/2021
1	Dexmedetomidine FDA Link 01/2021
1	Tripartite Motif ProteinsIBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	alectinibIBA 01/2021
1	Therapeutic UsesIBA 01/2021

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 01/2023 - 04/2011
19	Therapeutics 03/2024 - 12/2013
4	Immunotherapy 01/2023 - 11/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2023 - 03/2017
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 01/2017
1	Castration 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Transplantation 01/2021